nvt betreft homeopathische geneesmiddelproef bij gezonde vrijwilligers not applicable
Conditions
Interventions
Homeopathic Medicine Aspergillus ruber C12 for oral administration versus
placebo
Sponsors
SANUM-Kehlbeck GmbH & Co. KG
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: •Between 18 years and 75 years old. •Written informed consent •Able to understand and read the Dutch language •Accessible by telephone or internet
Exclusion criteria
Exclusion criteria: •Subjects with serious mental-emotional disorders such as psychosis, major depression, anxiety disorder, bipolar disorder or similar. •Planned medical/dental treatment during the HDP, including herbal or dietary supplements, procedures or medications that might interfere with, or substantially alter responsiveness of the participants to the homeopathic medicine proved. The use of contraceptive medication or intra-uterine devices is not an exclusion criterion. •Pregnancy or lactation, or anticipating pregnancy during the course of the HPD. •A known history of drug, alcohol and/or medication dependence or addiction •Participation in another trial at the same time or within the last 3 months prior to the study. •Current homeopathic treatment, or homeopathic treatment within 30 days prior to the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Proving symptoms experienced by the volunteers and attributable to the administration of the homeopathic medicine or placebo. For each symptom its properties are recorded according to a predefined scheme. | — |
Countries
Netherlands
Outcome results
None listed